glp-1 kidney protection and the kidney: from physiology to pharmacology and outcomes in diabetes Glucagon-Like Peptide-1 Receptor Agonist Use
Description
Whats so unique about these drugs is that they directly target the biological drivers underpinning obesity, says Meghan Podolsky, research fellow in the Department of Global Health (GH) and MS student in epidemiology, who is working on the project
, Dray, C
Read article Best Weight-Loss Medication: How to Choose There is no single best weight-loss medication, only the right one for you
These effects typically subside as your body adapts to the medication, though they may persist in 1015% of patients
State-Level Changes: Some states may consider pilot programs to study the long-term cost-effectiveness of covering these drugs
